Metrics raised 1
- PB Health break-even timeline: now expected by March 2027 (prior: March 2028)
Metrics cut 1
- Paisabazaar FY27 EBITDA: revised to ~₹50 crores (from ~₹100 crores earlier)
Event Participants
Executives
6 Yashish Dahiya, Alok Bansal, Sarbvir Singh, Santosh Agarwal, Mandeep Mehta, Mohit Khobragade
Analysts
8 Sachin Salgaonkar, Pravesh Jain, Dipanjan Ghosh, Sukrit Dutta, Jayant Kharote, Manas Agrawal, Shreya Shivani, Nitesh Jain
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Total Insurance Premium | ₹8,372 crores | Grew 41% YoY; led by protection categories as new health and term combined grew 53% |
| Consolidated Operating Revenue | ₹1,888 crores | Grew 40% YoY; core insurance revenue grew 46%, core credit revenue grew 25% |
| Total Credit Disbursement | ₹4,366 crores | Grew 33% YoY (Yashish initially stated 31% for disbursement growth, later corrected to 33%) |
| Consolidated PAT | ₹163 crores | Grew 92% YoY; PAT margin improved from 6% to 9% YoY |
| LTM PAT (Trailing 12 months) | Approx. ₹750 crores | Approaching the target number for the current fiscal year |
| Renewal Revenue (LTM) | ₹1,003 crores | Grew 55% YoY; previous three years of fresh growth starting to pay off in renewals |
| Core New Insurance Premium | — | Total grew 39% YoY; excluding savings grew 48% - amongst the highest levels ever recorded; 13 consecutive quarters above 35% growth excluding savings |
| Employee Benefit Expenses (as % of Revenue) | 15% | Was 12% in previous quarter (seasonally bigger); PBPartners top 100 partners share premium at 16% |
Geographic & Segment Commentary
Insurance (Policybazaar)
- Total premium grew 41% YoY to ₹8,372 crores. New health and term insurance grew 53% (new health at 59%). Growth driven by demand creation investment, attractively priced tailored products, and uplift in claims service quality. Over 30% of health business now comes from monthly payment mode, and 82% of business is from first-time insurance buyers. Claims CSAT above 90%; supported 70,000 health claims in the quarter.
Credit (Paisabazaar)
- Core revenue grew 25% YoY; core disbursements grew 33%. Operationally broke even in Q1, with contribution margin at 41%. Full-year EBITDA expectation revised to approximately ₹50 crores (half of earlier ₹100 crore guidance). Launching daily SIP platform from August 26, 2026, targeting self-employed consumers with lower monthly income visibility.
PBPartners
- Quarterly premium grew 46% YoY to ₹1,637 crores; revenue grew 47% to ₹561 crores. Active partner count up 55% YoY to 1.13 lakh advisors (500,000+ total). 78% of GWP comes from tier 2 and tier 3 cities, covering 99% of India's pin codes (19,000+). Top 100 partners share 16% of premium; company focused on reducing this concentration.
UAE
- Premium grew 31% YoY; primarily health and life insurance. Cross-border demand strong (retirees needing health insurance in India, children's education planning). Business described as resilient in tough times.
PB Health (PB Fintech's Own Hospitals)
- Total loss for the quarter approximately ₹7 crores. Received approval to start billing in second hospital. Fitterfly (acquired last year) monthly revenue up 4x since acquisition. Internal target: ₹500 crore annual run rate and break-even by March 2027.
Company-Specific & Strategic Commentary
AI Integration: 30-40% of 10 crore+ monthly customer interactions now touched by AI; 20-30% automatically handled. Focus on outcomes (sales productivity, conversion improvement) rather than token costs. Saved ₹10,000 crores of sum assured through risk models last year. Call center talk time reduced from ~2 hours at IPO to 35-40 minutes per health transaction.
PB Money / New Initiatives: 11 lakh consumers on PB Money platform. Bonds business license secured; standalone bonds platform launching end of August. Strategy includes diversifying customer bond investments across ~10 bonds to provide protection beyond a single bond.
Savings Business: Fresh business grew 21% in Q1. Waiver of Premium (WaP) plans expanded beyond children's plans to all goal-based savings; in some centers exceeded 60% of business in July. Gift City unit (started September) has become dominant retail insurance sales platform from Gift City, selling dollar plans to NRIs and new customers.
Hiring: Hired 5,000 employees at gross level in Q1 (seasonally weakest quarter), demonstrating commitment to growth over cost reduction.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Fresh Business Growth | P1 priority; target 30%+ | Management explicitly prioritizes fresh business growth over margin expansion; consistent communication internally and externally |
| Renewals Growth | Upwards of 50% for some time | Renewal growth expected to beat fresh growth over next 12 months as previous years' business matures |
| PAT Margin | 3% of premium target | Currently ~2% of premium; management indicated 3% "not very far off" |
| Paisabazaar EBITDA | ~₹50 crores for FY27 | Revised down from earlier ₹100 crore guidance; operationally broke even in Q1 |
| PB Health Run Rate | ₹500 crores annualized by March 2027 | Internal target; break-even expected by March 2027, not March 2028 |
| Q3 FY27 vs Q3 FY26 | Expect softer growth | Q3 last year benefited from exceptional GST-related demand; management emphasizes above-market growth focus rather than absolute levels |
| Savings Business | Waiver of Premium to drive acceleration | Expanded beyond children's plans; Gift City opening global investing spectrum |
Risks & Constraints
| Risk | Context |
|---|---|
| Regulatory - Effort-Based Commission | Regulator discussing effort-based commission changes; interpreted by some as asymmetric cuts across channels. Management notes legally brokers must put in maximum effort and declined to speculate on outcomes. Commission structure is foundational to business model profitability. |
| Regulatory - Dark Patterns | Discussions around phone number collection as potential "dark pattern." Management disputes characterization, citing global comparisons (Compare the Market, MoneySuperMarket collect phone numbers). If restricted, customer acquisition costs would rise materially. |
| H2 Base Effect | Q3 FY26 saw exceptional demand (GST-related); comparisons will be challenging. Management targets consistent above-market growth rather than absolute premium levels. |
| Motor Third-Party Extension | Supreme Court extended TP period; renewals will take longer to come in. New ticket sizes will rise (helps new business sellers). Management sees potential upside if enforcement improves per judgment (cameras, fuel restrictions for uninsured vehicles). |
| Paisabazaar Margin Shortfall | Full-year EBITDA expected at ~₹50 crores versus earlier ~₹100 crore guidance; business only operationally broke even in Q1. |
| Savings Product Reputation Risk | Market downturns could impact persistence and reputation for investment products. Persistence currently ~100 bps below peak. Management cites low-cost ULIP structures, verification processes, and transparency as mitigants. |
Q&A Highlights
Growth Drivers vs. Industry
- Question: Given industry health/term growth is slower, where is PB Fintech's 53-59% growth coming from? (Sachin Salgaonkar, BofA)
- Answer: Three pillars - demand creation investment, tailored well-priced products, and claims support uplift. Examples: monthly payment mode (30%+ of business), maternity product with 3-month waiting period (vs. industry 1-2 years). 82% of business is first-time insurance buyers. (Sarbvir Singh)
Margin Trajectory with Renewals
- Question: With renewals growing faster than fresh business, how should margins trend? (Sachin Salgaonkar, BofA)
- Answer: Renewals may bring scale but management deliberately reinvests in growth over bottom-line efficiency. "P1 is growth. Efficiency will come... We crossed 1% at some point. Right now we're at 2%. The 3% number isn't very far off." (Sarbvir Singh, Yashish Dahiya)
Regulatory - Effort-Based Commission & Manufacturing
- Question: Is worst-case scenario PB Fintech becoming a manufacturer? (Sachin Salgaonkar, BofA)
- Answer: Management declined to speculate. Noted brokers are legally required to put in maximum effort across tasks. Insurance demand is extremely low and requires significant effort. Generating inquiries and converting them are the cost-heavy parts; platform is "the easy part." Profits are "less than 1% of premium" without interest income. (Sarbvir Singh, Yashish Dahiya)
Claims Support & Health
- Question: How many claims are supported and what is the capacity? (Pravesh Jain, Motilal Oswal)
- Answer: 100% of claims that come to us are supported; 70,000 health claims in Q1. Typically 1.25-1.67% of policy base claims each quarter (~6% annually). Claims settlement is complex and time-consuming; many claims go through on their own, and PB Fintech serves as fallback for complex cases. (Yashish Dahiya, Sarbvir Singh)
Motor Business & Multi-Year Policies
- Question: Motor growth outlook and accounting of 3-year health policies? (Pravesh Jain, Motilal Oswal)
- Answer: Motor + two-wheeler direct business grew over 30%; POSP motor grew close to 50%. Premiums reported on collection basis (3-year premium shown upfront). Renewal measured by policy count - both first-year and second-year-plus renewals at all-time highs. Indexed (annualized) health growth is ~100 bps below reported growth. (Sarbvir Singh, Yashish Dahiya)
PB Health Targets
- Question: Any updates on PB Health? (Pravesh Jain, Motilal Oswal)
- Answer: Got approval for second hospital billing just before call. Losses ~₹7 crores for quarter. Fitterfly monthly revenue up 4x since acquisition. Target: ₹500 crore annual run rate and break-even by March 2027. Insurance will increasingly be the payor for Indian hospital billing, and PB Health aligns with this trend. (Yashish Dahiya)
Savings Business & Daily SIP
- Question: Why is savings soft, and what about Paisabazaar daily SIP monetization? (Dipanjan Ghosh, Citi)
- Answer: Savings fresh business grew 21%; Waiver of Premium expanded beyond children's plans (60%+ in some centers in July); Gift City dominant in retail insurance sales. Daily SIP targets self-employed segment with low savings product penetration; monetization 5-10% of Paisabazaar revenue in next 2 years - primarily stickiness play. (Sarbvir Singh, Santosh Agarwal)
PBPartners Scale vs. Profitability & Top 100 Concentration
- Question: Is POSP focused on scale or profitability? How to reduce top 100 concentration? (Sukrit Dutta, Goldman Sachs)
- Answer: Completely focused on scale; investment vs. expense distinction important. To reduce top 100 from 16%: increase partner count from ~1.2-1.4 lakh active quarterly toward the 12 lakh GI agent universe; accept lower productivity in tier 3/tier 4 where partner numbers are higher. (Sarbvir Singh, Dhruv)
Paisabazaar EBITDA & AI Strategy
- Question: Paisabazaar EBITDA performance? AI early harvest gains? (Jayant Kharote, Axis Capital)
- Answer: Paisabazaar broke even operationally; full-year EBITDA ~₹50 crores (half of earlier guidance). AI: 30-40% of 10 crore+ monthly interactions touched by AI; 20-30% handled automatically (document collection, status updates). Focus on outcomes not token burns. Sales productivity, risk models, customer service all improving. (Sarbvir Singh, Yashish Dahiya, Santosh Agarwal)
Dark Patterns & H2 Base
- Question: Dark patterns regulation impact? H2 base effect? AI call center productivity targets? (Manas Agrawal, Bernstein)
- Answer: No deception - phone number collection is disclosed upfront; global comparison sites also collect numbers. Q3 FY26 was exceptional; target is maintaining above-market growth. AI focus is on conversion improvement, not people reduction; growing both headcount and business. (Yashish Dahiya, Sarbvir Singh)
Cost Trajectory & Call Center Classification
- Question: Expense ratio improvement from 61% to 58%? Call center costs categorization? PB Connect numbers? (Shreya Shivani, Nomura)
- Answer: No intent to cut costs - revenue grew 40%, costs grew ~35%. Not yet in efficiency phase. All employee costs in employee benefit expenses. PB Connect wholesale business stopped (down 73% to ₹12 crores); corporate business ~₹500 crores, POSP ~₹1,600 crores, UAE ~₹500 crores. (Yashish Dahiya, Sarbvir Singh, Mandeep Mehta)
ULIP Persistence & Reputation Risk
- Question: Investment product underperformance and reputation risk? (Nitesh Jain)
- Answer: Persistence ~100 bps below peak despite tough markets. Sales process emphasizes equity-linked nature; independent verification calls; products are lowest-cost ULIPs in market - many cheaper than mutual funds despite mortality charges. 82% of business is first-time insurance buyers. (Sarbvir Singh)
PB Money Metrics
- Question: PB Money active users? (Nitesh Jain)
- Answer: 11 lakh consumers on PFM platform. PB Money entity (bonds business) launching end of August. Bonds strategy includes diversification across ~10 bonds per customer for protection. (Santosh Agarwal, Yashish Dahiya)
Key Takeaway
PB Fintech delivered another quarter of strong operational performance with consolidated revenue up 40% YoY to ₹1,888 crores and PAT up 92% to ₹163 crores (margin expanding from 6% to 9%). Total insurance premium grew 41% to ₹8,372 crores with core health and term growing 53%, driven by differentiated products, claims service (70,000 claims supported, CSAT >90%), and demand generation. Renewal revenue grew 55% to ₹1,003 crores, setting up sustained compounding — management expects renewals growth above 50% for some time. Management explicitly prioritizes fresh business growth over margin expansion, targeting full-year PAT approaching ₹750 crores (LTM) and a 3% margin on premium. Paisabazaar operationally broke even with contribution margin at 41% and core credit disbursements growing 33%. Strategic focus remains on AI-driven customer experience transformation, PB Health (targeting ₹500 crore run rate and break-even by March 2027), PBPartners scale-up (active partners +55% YoY), and new initiatives like daily SIPs and bonds platform. Key watch points: regulatory developments on effort-based commission, dark pattern discussions affecting lead generation costs, H2 base effects from GST-driven Q3 FY26 volumes, and Paisabazaar EBITDA tracking below earlier guidance at ~₹50 crores for FY27.